Creatine Composition for Brain Energy in Post-Viral Fatigue
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a lack of effective treatments for post-viral fatigue syndrome (PVFS) caused by SARS-COV-2 infection, particularly addressing symptoms such as mental fatigue, reduced motivation, and concentration difficulties, due to the complexity and uncertainty of the underlying causes and symptoms associated with Post-COVID.
Innovation Solution
Administration of creatine, either alone or in combination with glucose, to enhance creatine uptake in the brain, thereby improving mental status and increasing time to exhaustion in patients with PVFS.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If creatine is administered to patients with PVFS, then mental fatigue, reduced motivation, and concentration difficulties are improved, but the complexity of PVFS and uncertainty of underlying causes make treatment difficult to standardize
Solution Approach 1:
The patent applies parameter changes by adjusting creatine dosage (3-30g per day) and duration (8-24 weeks) to optimize treatment effectiveness. By systematically varying these parameters, the invention establishes standardized treatment protocols that improve reliability despite the complex and uncertain nature of PVFS.
Solution Approach 2:
The patent incorporates feedback mechanisms through monitored assessment of treatment response, allowing for adjustments in dosage and duration based on individual patient progress. This feedback loop enables standardization of effective treatment parameters while adapting to the complexity of each patient's condition.
2Reliability
If creatine supplementation is used to treat PVFS, then mental status improves and time to exhaustion increases, but lack of strong clinical trial data limits evidence-based recommendations
Solution Approach 1:
The patent applies preliminary action by conducting systematic reviews and meta-analyses of existing clinical trials before establishing treatment recommendations. This preliminary synthesis of evidence allows for evidence-based guidelines to be formulated, improving measurement precision of treatment effectiveness despite the limited number of individual trials.
Solution Approach 2:
The patent establishes specific dosage parameters (3-30g creatine per day) and duration parameters (8-24 weeks) based on analysis of clinical trial data. By defining these parameters precisely, the invention improves the measurement precision of treatment effectiveness, enabling more reliable recommendations despite the heterogeneous nature of existing studies.
3Ease of operation
If behavioral advice and gradual activity increase are recommended for PVFS, then recovery is supported, but these non-pharmaceutical measures are insufficient for severe cases
Solution Approach 1:
The patent applies segmentation by dividing treatment into two complementary components: (1) behavioral and lifestyle modifications (easy to implement), and (2) creatine supplementation (pharmaceutical intervention). This segmentation allows simple interventions to be combined with targeted pharmaceutical treatment, improving overall reliability while maintaining ease of operation through clear implementation guidelines.
Solution Approach 2:
The patent merges behavioral advice and creatine supplementation into a comprehensive treatment protocol. By combining these approaches, the invention achieves both ease of operation (through structured guidance) and improved reliability (through pharmacological augmentation), addressing the insufficiency of non-pharmaceutical measures alone.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Creatine supplementation significantly enriches brain areas like the thalamus, grey matter, and white matter, effectively alleviating mental fatigue, reduced motivation, and concentration difficulties in Post-COVID patients, with potential benefits when combined with pulmonary rehabilitation.
Implementation Method 1
Creatine plays a vital role in the energy metabolism in every cell of the body. It mainly serves as a metabolic intermediary of energy transfer by facilitating the recycling of ATP, the source of energy for use and storage at the cellular level.
Implementation Method 2
the blood-brain barrier. Within the framework of the present invention it has been found, however, that seemingly long-COVID or Post-COVID causes changes in the blood-brain barrier so that a creatine uptake and enrichment in brain areas such as the thalamus, grey matter and white matter, specifically in post-COVID situations was observed.
Data Source
AI summary
The present invention relates to a pharmaceutical composition comprising creatine or physiologically acceptable derivatives and/or salts and or adducts thereof for use in the treatment of PVFS, in particular associated with mental fatigue, reduced motivation, reduced activity, or concentration difficulties. A further embodiment of the invention relates to the use of a composition comprising creatine or physiologically acceptable derivatives and/or salts and or adducts thereof as dietary supplement for preparation of a diet supporting the recovery from PVFS.